Menu
Log in
Forgot password
Log in
Forgot password

News

  • Home
  • Resources
  • Literature Updates
  • Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis

Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis

21 Feb 2025 9:48 AM | Anonymous member (Administrator)

Oh, Jung-Hwan ; Kim, Hyun-Soo; Cheung, Dae Young ; Lee, Hang Lak ; Lee, Dong Ho; Kim, Gwang Ha ; Choi, Suck Chei ; Cho, Yu Kyung ; Chung, Woo Chul ; Kim, Ji Won ; Yu, Eunju; Kwon, Hyesoo ; Kim, Jun ; Kim, John; Jung, Hwoon-Yong

Read Abstract: Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software